Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Applied Nanotech Board Elects Paul Rocheleau Vice-Chairman

Abstract:
Applied Nanotech Holdings, Inc. (OTC BB: APNT) announced that Paul Rocheleau has been elected Vice-Chairman of the Company's Board of Directors. In his role as Vice-Chairman, Paul will take an increased role in guiding company activities, with a focus on helping monetize our intellectual property by exposing it to strategic users with the ability to bring product rapidly to market and generate revenue for the Company.

Applied Nanotech Board Elects Paul Rocheleau Vice-Chairman

Austin, TX | Posted on November 23rd, 2009

Mr. Rocheleau has extensive experience in the global materials and chemicals industry. He is currently Chairman of the Board and Chief Investment Officer of Virginia Biosciences Commercialization Center. Over the past three years, he provided strategic and financial advisory services for a range of technology and industrial companies as a Managing Director at Cary Street Partners, a regional investment banking firm based in Richmond, Virginia. Prior experience included positions as Senior VP and Chief Financial Officer of Albermarle Corporation, a $2.0 Billion NYSE listed chemical company, and 15 years, including three as CEO, with Albright & Wilson, PLC, a $1.2 billion multinational chemical company.

Mr. Rocheleau currently serves on the Board of Directors of NanoChemonics, a specialty nano- materials company and serves on the Advisory Board Apex Systems, a $400 million IT staffing company. He also is a Founding Trustee of the Virginia Commonwealth University School of Engineering, where he currently serves as President of the Foundation.

"Paul has become integrally involved with us as a strategic advisor," said Doug Baker, Chief Executive Officer of APNT. "His new perspective has been invaluable to us and his increased level of involvement will be very helpful to us as we continue to increase our revenue and move the company to profitability."

"I am excited by the wealth of opportunities in front of us," said Paul Rocheleau, Director of APNT. "I am looking forward to helping bring these revolutionary technologies to market."

"All of our Board Members are working harder than ever to make the company successful," said Dr. Robert Ronstadt, Chairman of APNT. "It is encouraging to see that Paul is willing to go above and beyond the call of duty. His background in strategy and financing of emerging technologies will be very helpful in the years ahead."

The Company also announced that its updated website is live today. Investors are invited to submit comments or suggestions related to the website through the investor contact information on the website, or through the contact information [below].

Safe Harbor Statement
This press release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report on Form 10-K for the fiscal year ended December 31, 2008, and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at www.sec.gov or from our website listed above. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.

####

About Applied Nanotech Holdings
Applied Nanotech Holdings, Inc. is a premier research and commercialization organization focused on solving problems at the molecular level. Its team of PhD level scientists and engineers work with companies and other organizations to solve technical impasses and create innovations that will create a competitive advantage. The business model is to license patents and technology to partners that will manufacture and distribute products using the technology. Applied Nanotech has over 250 patents or patents pending. APNT also possesses investments related to electronic digitized sign technology.

For more information, please click here

Contacts:
Doug Baker
Applied Nanotech Holdings, Inc.
248.391.0612

Copyright © Applied Nanotech Holdings

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Virginia Tech physicists propose path to faster, more flexible robots: Virginia Tech physicists revealed a microscopic phenomenon that could greatly improve the performance of soft devices, such as agile flexible robots or microscopic capsules for drug delivery May 17th, 2024

Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024

Shedding light on perovskite hydrides using a new deposition technique: Researchers develop a methodology to grow single-crystal perovskite hydrides, enabling accurate hydride conductivity measurements May 17th, 2024

Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024

Announcements

Virginia Tech physicists propose path to faster, more flexible robots: Virginia Tech physicists revealed a microscopic phenomenon that could greatly improve the performance of soft devices, such as agile flexible robots or microscopic capsules for drug delivery May 17th, 2024

Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024

Finding quantum order in chaos May 17th, 2024

Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

Appointments/Promotions/New hires/Resignations/Deaths

The National Space Society Mourns the Passing of Robert Krone, Founder of the Kepler Space Institute: Krone's Visionary and Humanistic Approach to the Study of Space Communities and Settlement Was Unique September 22nd, 2021

Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021

JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021

The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project